Surgery Doctors in Fridley, MN Accepting Medicare

8 Surgery doctors found. Showing 1 - 8

Lorraine Woidylla, APRN, CNP Surgery - Trauma Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 Osborne Rd Ne, Fridley, MN 55432 Phone: 763-236-5000    Fax: 763-236-3433

Dr. Daniel R Baker, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 Osborne Rd Ne, Suite 200, Fridley, MN 55432 Phone: 763-236-2045    Fax: 763-236-2044

Dr. Dale Lee Cody, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Osborne Rd Ne Ste 255, Fridley, MN 55432 Phone: 763-236-2500    Fax: 763-236-2505

Dr. Laura Violet July, MD Surgery Medicare: Medicare Enrolled Practice Location: 500 Osborne Rd Ne Ste 200, Fridley, MN 55432 Phone: 763-236-2045    Fax: 763-236-2044

Dr. Frederick W Johnson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 500 Osborne Rd Ne, Suite 200, Fridley, MN 55432 Phone: 763-236-2045    Fax: 763-236-2044

Dr. Peter James Halvorson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6341 University Ave Ne, Fridley, MN 55432 Phone: 763-572-5710    Fax: 763-586-5888

Dr. Thomas Charles Tunberg, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 6341 University Ave Ne, Fridley, MN 55432 Phone: 763-572-5710    Fax: 763-586-5888

Dr. Jeffrey D Baker, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Osborne Rd Ne, Suite 200, Fridley, MN 55432 Phone: 763-236-2045    Fax: 763-236-2044

News Archive

JDRF to begin diabetes research collaboration on drugs for replicating insulin-producing cells

The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.

Boston Heart Diagnostics announces commercial launch of FDA-cleared MPO test

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced the commercial launch of an FDA-cleared MPO (myeloperoxidase) test, a key biomarker for inflammation. Studies show that MPO levels are useful predictors of near-term (one to six months) risk of heart attack or stroke.

Early learning experts join forces to endorse blueprint for education reform

The province's leading early learning experts and champions of publicly funded education are joining forces to endorse the Blueprint for education reform proposed by the Premier's Early Learning Advisor.

Abbreviated breast MRI may be valuable cancer detection tool for women with dense breasts

Among women with dense breast tissue, for whom traditional mammograms are less effective at detecting cancer, who request additional screening after a negative mammogram, abbreviated breast MRI may be a valuable cancer detection tool.

Read more Medical News

› Verified 7 days ago